Of America Corp /De/ Bank Purchases 670 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank bought 670 shares of the business’s stock in a transaction on Tuesday, July 26th. The stock was bought at an average price of $27.97 per share, for a total transaction of $18,739.90. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

HCA Healthcare Trading Down 0.0 %

Shares of HCA stock traded down $0.09 on Friday, reaching $342.25. 1,114,475 shares of the stock were exchanged, compared to its average volume of 1,343,785. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a 50 day moving average price of $323.90 and a 200 day moving average price of $341.86. The stock has a market cap of $84.26 billion, a PE ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm posted $5.90 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s payout ratio is presently 13.11%.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $39,000. Whipplewood Advisors LLC bought a new stake in HCA Healthcare during the fourth quarter valued at approximately $31,000. Tidemark LLC purchased a new position in HCA Healthcare during the fourth quarter valued at approximately $36,000. Activest Wealth Management boosted its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. increased its holdings in shares of HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of a number of research reports. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Morgan Stanley dropped their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Bank of America reduced their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Finally, Barclays decreased their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.